학술논문
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial
Document Type
Article
Author
Source
In: Trials . (Trials, December 2022, 23(1))
Subject
Language
English
ISSN
17456215